pharma.markets

  • HOME
  • Imprint

enterprises

State aid: EU Commission approves Polish recapitalisation scheme to enable up to €1.65 billion of capital support to SMEs and large enterprises affected by the coronavirus outbreak

13/06/2020 MaP 0

The European Commission has approved a Polish recapitalisation scheme of up to €1.65 billion (PLN 7.5 billion) to support large enterprises and certain larger small […]

State aid: EU Commission approves €2.2 billion Polish subsidised loan scheme for large enterprises affected by coronavirus outbreak

26/05/2020 MaP 0

The European Commission has approved a Polish subsidised loan scheme to support large enterprises in the context of the coronavirus outbreak. The measure was approved […]

State aid: EU Commission approves prolongation and modification of the French “Fonds de solidarité” scheme for small enterprises

15/04/2020 MaP 0

….in temporary financial difficulties due to coronavirus outbreak The European Commission has found France’s prolongation and modification of a previously approved scheme to support small […]

State aid: Commission approves €1.2 billion French “Fonds de solidarité” scheme

31/03/2020 MaP 0

….for small enterprises in temporary financial difficulties due to coronavirus outbreak The European Commission has found France’s €1.2 billion scheme to support small and micro-enterprises […]

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Animal health
  • Asthma
  • Cancer
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • UN
  • Vaccines

Reports

  • Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine
  • Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
  • EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries
  • In Vitro Study Published in The New England Journal of Medicine
  • Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

Archive

  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine

    25/02/2021 0
  • Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants

    25/02/2021 0
  • Copyright European Commission 2021

    EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries

    20/02/2021 0
  • In Vitro Study Published in The New England Journal of Medicine

    17/02/2021 0
  • Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

    17/02/2021 0
Archives
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid biontech cancer commission companies coronavirus covid-19 covid19 crisis economy elpais.com eu europe european fda fight food global guarantee health hygiene italy links medical merck novartis pandemic pfizer production products recommendations region response roche safety scheme sector spain state statistics stats support vaccine

Copyright © 2021 | WordPress Theme by MH Themes